期刊
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
卷 11, 期 9, 页码 -出版社
COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a038653
关键词
-
资金
- Australian Government Department of Health
Live attenuated, cold-adapted influenza vaccines have desirable characteristics, but recent studies have shown reduced replicative fitness of some H1N1pdm09 viruses, affecting the effectiveness of LAIVs. Careful selection of vaccine strains is needed, and a better understanding of replicative fitness and vaccine effectiveness is essential to maximize the potential of these valuable vaccines.
Live attenuated, cold-adapted influenza vaccines exhibit several desirable characteristics, including the induction of systemic, mucosal, and cell-mediated immunity resulting in breadth of protection, ease of administration, and yield. Seasonal live attenuated influenza vaccines (LAIVs) were developed in the United States and Russia and have been used in several countries. In the last decade, following the incorporation of the 2009 pandemic H1N1 strain, the performance of both LAIVs has been variable and the U.S.-backbone LAIVwas less effective than the corresponding inactivated influenza vaccines. The cause appears to be reduced replicative fitness of some H1N1pdm09 viruses, indicating a need for careful selection of strains included in multivalent LAIV formulations. Assays are now being implemented to select optimal strains. An improved understanding of the determinants of replicative fitness of vaccine strains and of vaccine effectiveness of LAIVs is needed for public health systems to take full advantage of these valuable vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据